193 related articles for article (PubMed ID: 38097715)
1. Sigma-1 receptor activation mediates the sustained antidepressant effect of ketamine in mice via increasing BDNF levels.
Ma H; Li JF; Qiao X; Zhang Y; Hou XJ; Chang HX; Chen HL; Zhang Y; Li YF
Acta Pharmacol Sin; 2024 Apr; 45(4):704-713. PubMed ID: 38097715
[TBL] [Abstract][Full Text] [Related]
2. IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine.
Deyama S; Kondo M; Shimada S; Kaneda K
Transl Psychiatry; 2022 May; 12(1):178. PubMed ID: 35577782
[TBL] [Abstract][Full Text] [Related]
3. Cortical and raphe GABA
Pham TH; Defaix C; Nguyen TML; Mendez-David I; Tritschler L; David DJ; Gardier AM
Pharmacol Biochem Behav; 2020 May; 192():172913. PubMed ID: 32201299
[TBL] [Abstract][Full Text] [Related]
4. Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT
Fukumoto K; Fogaça MV; Liu RJ; Duman CH; Li XY; Chaki S; Duman RS
Neuropsychopharmacology; 2020 Sep; 45(10):1725-1734. PubMed ID: 32396921
[TBL] [Abstract][Full Text] [Related]
5. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine.
Deyama S; Duman RS
Pharmacol Biochem Behav; 2020 Jan; 188():172837. PubMed ID: 31830487
[TBL] [Abstract][Full Text] [Related]
6. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
[TBL] [Abstract][Full Text] [Related]
7. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2
Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184
[TBL] [Abstract][Full Text] [Related]
8. Partial mGlu
Pałucha-Poniewiera A; Rafało-Ulińska A; Santocki M; Babii Y; Kaczorowska K
Pharmacol Rep; 2024 Jun; 76(3):504-518. PubMed ID: 38632187
[TBL] [Abstract][Full Text] [Related]
9. Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine.
Yao W; Cao Q; Luo S; He L; Yang C; Chen J; Qi Q; Hashimoto K; Zhang JC
Mol Psychiatry; 2022 Mar; 27(3):1618-1629. PubMed ID: 34819637
[TBL] [Abstract][Full Text] [Related]
10. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.
Zhang JC; Yao W; Dong C; Yang C; Ren Q; Ma M; Han M; Hashimoto K
Psychopharmacology (Berl); 2015 Dec; 232(23):4325-35. PubMed ID: 26337614
[TBL] [Abstract][Full Text] [Related]
12. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
Yang C; Kobayashi S; Nakao K; Dong C; Han M; Qu Y; Ren Q; Zhang JC; Ma M; Toki H; Yamaguchi JI; Chaki S; Shirayama Y; Nakazawa K; Manabe T; Hashimoto K
Biol Psychiatry; 2018 Oct; 84(8):591-600. PubMed ID: 29945718
[TBL] [Abstract][Full Text] [Related]
13. BDNF release and signaling are required for the antidepressant actions of GLYX-13.
Kato T; Fogaça MV; Deyama S; Li XY; Fukumoto K; Duman RS
Mol Psychiatry; 2018 Oct; 23(10):2007-2017. PubMed ID: 29203848
[TBL] [Abstract][Full Text] [Related]
14. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
[TBL] [Abstract][Full Text] [Related]
15. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
Zhou W; Wang N; Yang C; Li XM; Zhou ZQ; Yang JJ
Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772
[TBL] [Abstract][Full Text] [Related]
16. The duration of the antidepressant-like effects of a single infusion of brain-derived neurotrophic factor into the medial prefrontal cortex in mice.
Deyama S; Kaneda K
Behav Brain Res; 2020 Sep; 394():112844. PubMed ID: 32745661
[TBL] [Abstract][Full Text] [Related]
17. Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine.
Dong C; Zhang JC; Yao W; Ren Q; Ma M; Yang C; Chaki S; Hashimoto K
Int J Neuropsychopharmacol; 2017 Mar; 20(3):228-236. PubMed ID: 27765808
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex.
Deyama S; Aoki S; Sugie R; Fukuda H; Shuto S; Minami M; Kaneda K
Neurotherapeutics; 2023 Mar; 20(2):484-501. PubMed ID: 36622634
[TBL] [Abstract][Full Text] [Related]
19. VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine.
Jiang C; Lin WJ; Labonté B; Tamminga CA; Turecki G; Nestler EJ; Russo SJ; Salton SR
Neuropsychopharmacology; 2019 Apr; 44(5):971-981. PubMed ID: 30504797
[TBL] [Abstract][Full Text] [Related]
20. Fast antidepressant action of ketamine in mouse models requires normal VGLUT1 levels from prefrontal cortex neurons.
Belloch FB; Cortés-Erice M; Herzog E; Zhang XM; Díaz-Perdigon T; Puerta E; Tordera RM
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110640. PubMed ID: 36209771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
